Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

A guy gets his testosterone tested, the results come back – say, 450 ng/dL – and that’s it. No context, no comparison, nothing. Is 450 good? Bad? Fine for someone his age but a red flag for a twenty-five-year-old? Most people walk out of that appointment more confused than when they walked in, mainly because […]

The post Normal Testosterone Levels by Age: What’s Actually Healthy at Every Stage of Life appeared first on Medical News Bulletin.

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

When you agree to a remote clinical trial—a trial where data is collected straight from your bedroom, wrist, or phone—what exactly are you agreeing to? With decentralized clinical trials, or DCTs, becoming more common, it’s worth understanding what these remote trials are actually like. Here’s what you should know before you sign up. What “Decentralized” […]

The post When a Clinical Trial Moves Into Your Living Room appeared first on Medical News Bulletin.

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Being told that your corneas are “too thin for LASIK” can sound like the end of the laser eye surgery conversation. It usually is not that simple. Corneal thickness matters as laser vision correction reshapes the cornea by removing or extracting tissue. Leave too little structurally useful tissue behind, and the risk of postoperative weakening […]

The post Too Thin For LASIK? The Answer Is More Complicated Than It Sounds appeared first on Medical News Bulletin.

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Have you heard? Polycystic ovarian syndrome is getting a name change! The international medical community has decided that from now on PCOS will be called polyendocrine metabolic ovarian syndrome (PMOS).   Gynaecologists and endocrinologists have updated the name to reflect their modern understanding of the condition. Over the last few decades, women’s health specialists have come […]

The post Why is PCOS now PMOS? appeared first on Medical News Bulletin.

Vaccine coverage among America’s kindergarteners continues to decline as exemptions grow, according to data for the 2025-2026 school year released this week by the CDC.
According to the data, vaccination coverage for measles, mumps and rubella declined from 92.5% the previous school year to 92.4% last year, and coverage against diphtheria, tetanus and pertussis declined from 92.1% to 92%.
“What [the] data show is that over 92% of kindergarteners in the United States are vaccinated,” AAP President Andrew D. Racine, MD, PhD, FAAP, said in a press release. “When it comes to vaccination rates,

In my previous article, I discussed practical functional tests and systemic biomarkers that can be used to assess retinal reserve. Identifying these biomarkers is only the first step. Their true value lies in how they are interpreted.
Traditionally, retinal disease is classified by structural diagnosis. Patients are labeled as having age-related macular degeneration, glaucoma or diabetic retinopathy, and management generally follows established disease-specific guidelines.
Retinal reserve asks a different question. Rather than asking, "What disease does this patient have?" it asks, "What

The conduct of federally sponsored cancer clinical trials requires millions in drug costs, but expenditures are significantly less when led by another sponsor.
An evaluation of nearly 1,400 federally sponsored studies showed the median cost per trial exceeds $7.5 million, but for trials solely led by federal researchers, the expenditures are more than $11 million.
Additionally, the median drug costs for phase 3 studies are almost $60 million, those evaluating immunotherapies and targeted agents are significantly higher than those involving chemotherapy, and the cost for experimental agents are

The phase 3 LUGANO trial investigating Duravyu for wet AMD did not meet its primary endpoint in the full dataset but showed positive results in treatment burden, supplement-free rates and anatomic control, according to a press release.
The randomized, double-masked, noninferiority LUGANO and LUCIA programs are investigating the safety and efficacy of Duravyu (vorolanib intravitreal insert, EyePoint Pharmaceuticals) vs. on-label aflibercept 2 mg as a treatment for wet age-related macular degeneration, with more than 900 patients enrolled across both trials. The primary endpoint looked at

Habitual protein intake was not associated with iohexol-measured GFR decline for adults without chronic kidney disease, according to study data published in Clinical Kidney Journal.
Previous studies explored associations between protein intake and kidney function, but many used eGFR as opposed to measured GFR, according to Ludvig Balteskard Rinde, MD, PhD, associate professor in the department of clinical medicine at UiT The Arctic University of Norway, Tromsø, and colleagues.
“High protein intake increases renal blood flow and intraglomerular pressure and can cause hyperfiltration, which

Low sexual desire is a commonly reported symptom among menopausal women, often overlapping with androgen-sensitive dermatologic conditions such as acne, hirsutism and hair loss.
For midlife women seeking treatment for hypoactive sexual desire disorder (HSDD), some medications, such as spironolactone for acne or finasteride for hair loss, could worsen one condition while improving the other, according to Shoshana Marmon, MD, PhD, FAAD, assistant professor of dermatology at New York Medical College, and Melissa M. Mauskar, MD, associate professor of dermatology and obstetrics at UT Southwestern